Osteotech, Inc.

Osteotech, Inc. provides Osteo-Biologic solutions to surgeons and patients for the repair of the musculoskeletal system. It operates in five segments: Demineralized Bone Matrix (DBM), Traditional Tissue, Spinal Allograft, Hybrid/Synthetic, and Client Services. The DBM segment markets Grafton DBM, a bone graft substitute product; and Xpanse Bone Inserts. It processes Grafton DBM from allograft bone tissue recovered by tissue banks. The Traditional Tissue segment converts allograft bone tissue into mineralized weight-bearing forms, including femoral cross sections, fibula wedges, and cortical struts, as well as into nonweight bearing tissue forms, such as cancellous and cortical chips. The Spinal Allograft Segment distributes Bio-implant spacers and ramps that are used in spinal fusion procedures. The Hybrid/Synthetics segment offers GraftCage Spacers under the Plexur Biocomposites brand. The Client Services segment provides donor processing services. The company offers its products to the orthopaedic, neurological, oral/maxillofacial, and general surgery markets for spinal fusion procedures; to repair and replace bone loss caused by trauma or certain disease states; to augment prosthetic implant procedures; and to replace damaged ligaments and tendons. Osteotech distributes its products primarily through agents and sales representatives worldwide. The company was founded in 1986 and is based in Eatontown, New Jersey.